06:06:15 EDT Wed 08 May 2024
Enter Symbol
or Name
USA
CA



Ocumetics Technology Corp
Symbol OTC
Shares Issued 118,466,104
Close 2023-08-30 C$ 0.28
Market Cap C$ 33,170,509
Recent Sedar Documents

Ocumetics appoints Stulting, McRoberts as directors

2023-09-01 11:03 ET - News Release

Mr. Dean Burns reports

OCUMETICS WELCOMES DR. DOYLE STULTING AND DR. BART MCROBERTS TO BOARD OF DIRECTORS

Ocumetics Technology Corp. has appointed Dr. Robert Doyle Stulting and Dr. James Barton McRoberts to its board of directors. With their unparalleled expertise in ophthalmology and vision research, Dr. Stulting and Dr. McRoberts bring a wealth of knowledge that will help drive Ocumetics' innovation and commitment to improving eye care globally.

Dr. Stulting has authored over 250 papers in peer-reviewed journals, published several textbook chapters, taught courses for over 30 years at the American Academy of Ophthalmology and lectured around the world. He was awarded the American Academy of Ophthalmology's Lifetime Achievement Award and the Food and Drug Administration's Citation for Excellence, Commitment, and Outstanding Service in Protecting the Public. Dr. Stulting has served as the corporation's chief medical officer since Oct. 1, 2021.

Dr. McRoberts received his doctorate in optometry in 1974 from the University of Waterloo. He has managed a private clinical practice since 1974 in both Squamish and West Vancouver. Dr. McRoberts brings a vast array of experience to Ocumetics. Among other things, he has functioned as the professional services director of the Laser Center in Vancouver, the vice-president and a board member of Optometric Services Ltd. Montreal, and as the president of the British Columbia Association of Optometrists. Dr. McRoberts has also served as the registrar and deputy registrar for the College of Optometrists.

"Dr. Stulting and Dr. McRoberts are renowned figures in the field of eye care, and their visionary contributions will undoubtedly propel Ocumetics to new heights," commented Dr. Garth Webb, chairman of Ocumetics. "Their presence on our board reinforces our dedication to enhancing visual health and revolutionizing the way we approach eye care."

"As Ocumetics continues to push the boundaries of eye care, the addition of these accomplished professionals solidifies the company's mission to create a brighter, clearer future for individuals worldwide," adds Dean Burns, President and chief executive officer of Ocumetics.

About Ocumetics Technology Corp.

Ocumetics Technology is a Canadian research and product development company that specializes in adaptive lens designs. Ocumetics is in the preclinical study stage of a game-changing technology for the ophthalmic industry. Ocumetics has developed an expandable intraocular lens that fits within the natural lens compartment of the eye potentially to eliminate the need for corrective lenses. It is designed to allow the eye's natural muscle activity to shift focus from distance to near.

© 2024 Canjex Publishing Ltd. All rights reserved.